COVID-19 pandemic challenges: on the way to overcome obstacles in realization of PAH-specific therapy treatment goals
Our observation demonstrates a case of a 40-year-old female with idiopathic pulmonary arterial hypertension World Health Organization functional class III, who was admitted to NMRC of Cardiology repeatedly due to disease progression including dyspnea worsening and exercise tolerance decrease after p...
Saved in:
| Main Authors: | E. A. Rezukhina, I. Z. Korobkova, N. M. Danilov, V. V. Gramovich, T. V. Martynyuk |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
InterMedservice
2021-11-01
|
| Series: | Евразийский Кардиологический Журнал |
| Subjects: | |
| Online Access: | https://www.heartj.asia/jour/article/view/6293 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patient and disease characteristics of pulmonary arterial hypertension patients for prostacyclin receptor agonist selexipag treatment initiation
by: E. A. Rezukhina, et al.
Published: (2023-03-01) -
Historical milestones in the study of pulmonary hypertension
by: Anna K. Osokina, et al.
Published: (2025-01-01) -
Profile of patients with portopulmonary hypertension
by: M. K. Barkovskaya, et al.
Published: (2025-06-01) -
EXPERIENCE OF IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION PATIENTS MANAGEMENT IN URAL FEDERAL DISTRICT: FEATURES OFOUTPATIENT-HOSPITAL INTERACTIONS
by: S. V. Shalaev, et al.
Published: (2019-03-01) -
Possibilities of long-term effective treatment of idiopathic pulmonary arterial hypertension by replacing sildenafil with riociguat and using sequential combination therapy: case report
by: S. A. Musashaykhova, et al.
Published: (2022-12-01)